American Journal of Hematology
Издатель: Wiley · ISSN 03618609 · 58 статей
-
Is There an Association Between GLP‐1RA Use and Blood Cancer Incidence or Progression?
American Journal of Hematology, EarlyView.
-
Ravulizumab Shows Favorable Survival and Improves Clinical Markers in Children With HSCT‐TMA: Results of a Phase 3 Trial
ABSTRACT Hematopoietic stem cell transplantation‐associated thrombotic microangiopathy (HSCT‐TMA) is a rare, life‐threatening complication that can lead to multiorgan failure and death. The ALXN1210‐TMA‐314 global, Phase 3, open‐label,...
-
Longitudinal Kidney Function Trajectories and Their Association With Hemoglobin and Transfusion Phenotype in Adults With β‐Thalassemia
ABSTRACT Renal functional trajectories and their associations with hemoglobin exposure remain incompletely characterized in adults with β‐thalassemia. We analyzed 994 adults (806 transfusion‐dependent thalassemia [TDT], 188...
-
Is Bone Marrow Examination Still Required at Diagnosis of Typical Chronic‐Phase Chronic Myeloid Leukemia? Evidence From Paired Peripheral Blood and Bone Marrow Cytogenetics
American Journal of Hematology, EarlyView.
-
Distinct Consequences of BCOR and BCORL1 Mutations in Myeloid Neoplasms and Bone Marrow Failure
ABSTRACT BCOR and BCORL1 (BCOR/L1 ) mutations are observed in both myeloid neoplasms (MN) and bone marrow failure syndromes (BMF), but their clinical significance may differ. We analyzed 11 340 patients and identified 418 BCOR/L1...
-
Use of RBC Parameters to Establish Functional Ferritin Cutoffs for the Potential Diagnosis of Iron Deficiency in Adults and Children
American Journal of Hematology, EarlyView.
-
Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk‐Stratification, and Treatment
American Journal of Hematology, Volume 101, Issue 12, Page 3010-3031, December 2026.
-
Cerebral Small Vessel Disease in Immune‐Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission
American Journal of Hematology, Volume 101, Issue 12, Page 3001-3009, December 2026.
-
Venetoclax Plus Hypomethylating Agent for 7‐ Versus 14‐ Versus 21‐ Versus 28‐Day Cycles in Newly‐Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk–Stratified Analysis in 540 Patients
American Journal of Hematology, Volume 101, Issue 12, Page 2990-3000, December 2026.
-
Splenic Tropism and Spleen‐Modulated Systemic Inflammation in Acute
Plasmodium vivax
Malaria
American Journal of Hematology, Volume 101, Issue 12, Page 2976-2989, December 2026.
-
The Presence and Percentage of Circulating Nucleated Red Blood Cells Reveal Distinct Characteristics in Adults With Sickle Cell Disease
American Journal of Hematology, Volume 101, Issue 12, Page 2961-2975, December 2026.
-
Anticoagulant Therapy and Bleeding‐Related Hospitalizations in Patients With Cancer: A National Cohort Study
American Journal of Hematology, Volume 101, Issue 12, Page 3047-3051, December 2026.
-
Radiation‐Free Haploidentical Transplantation With PTCy and Extended Abatacept in Pediatric Nonmalignant Disorders
American Journal of Hematology, Volume 101, Issue 12, Page 3082-3086, December 2026.
-
Superficial Vein Thrombosis During Pregnancy and Postpartum—Findings From the French Multicenter Cohort “HEMOTHEPP” Study
American Journal of Hematology, Volume 101, Issue 12, Page 3059-3066, December 2026.
-
Clonally Related Chronic Lymphocytic Leukemia and Malignant Histiocytic Neoplasm (Histiocytic Sarcoma With Overlapping Langerhans Cell Phenotype): Divergent Evolution From a Shared Cell‐Of‐Origin
American Journal of Hematology, Volume 101, Issue 12, Page 3036-3042, December 2026.
-
Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy
American Journal of Hematology, Volume 101, Issue 12, Page 3067-3071, December 2026.
-
Real‐World Experience of Mitapivat in Pyruvate Kinase Deficiency
American Journal of Hematology, Volume 101, Issue 12, Page 3054-3058, December 2026.
-
Obesity‐Related Inflammation Masks Iron Deficiency in US Women
American Journal of Hematology, Volume 101, Issue 12, Page 3043-3046, December 2026.
-
Response to “Undetectable Hydroxyurea in an Untimed Blood Sample Does Not Establish Nonadherence”
American Journal of Hematology, Volume 101, Issue 12, Page 3077-3078, December 2026.
-
Soluble Transferrin Receptor and the sTfR/Log Ferritin Index May Not Be Better Than Ferritin Alone for Diagnosis of Anemia of Chronic Disease and Iron Deficiency Anemia
American Journal of Hematology, Volume 101, Issue 12, Page 3079-3081, December 2026.
-
Ferritin Alone Is Not Sufficient to Diagnose Iron Deficiency in Patients With Anemia due to Chronic Disease
American Journal of Hematology, Volume 101, Issue 12, Page 3072-3073, December 2026.
-
What Does “Non‐Transfusion‐Dependent” Measure in Clinical Trials?
American Journal of Hematology, Volume 101, Issue 12, Page 3074-3076, December 2026.
-
Could Mixed CAR T‐Cell Products and Overlapping Patients Overestimate the Risk of HLH With Tisagenlecleucel?
American Journal of Hematology, Volume 101, Issue 12, Page 3052-3053, December 2026.
-
Issue Information
American Journal of Hematology, Volume 101, Issue 12, Page 2953-2955, December 2026.
-
Overall Survival Benefit and Long‐Term Safety of Romiplostim in Persistent Chemotherapy‐Induced Thrombocytopenia
American Journal of Hematology, Volume 101, Issue 12, Page 2957-2960, December 2026.
-
Noninvasive Diagnosis of Splenosis Using Tc‐99m Heat‐Denatured Red Blood Cell Scintigraphy
American Journal of Hematology, Volume 101, Issue 12, Page 3034-3035, December 2026.
-
Basophilic Stippling Unmasks Pyrimidine 5′‐Nucleotidase Deficiency in a G6PD‐Deficient Patient
American Journal of Hematology, Volume 101, Issue 12, Page 3032-3033, December 2026.
-
Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL
ABSTRACT Pirtobrutinib, a highly selective, non‐covalent Bruton tyrosine kinase inhibitor (BTKi) previously demonstrated durable efficacy and tolerable safety following covalent (c) BTKi therapy in heavily pretreated relapsed/refractory...
-
Follicular Lymphoma: 2027 Annual Update
ABSTRACT Background Follicular lymphoma (FL) is the most common indolent lymphoma and has widely variable disease trajectories. While patients with a durable response to initial therapy have expected survival comparable to the general...
-
Targeted Sequencing Yields High Rate of Pathogenic Variants in Both Single and Multilineage Pediatric Immune Cytopenias
American Journal of Hematology, EarlyView.